SAN DIEGO–(BUSINESS WIRE)–San Diego Angel Conference, a University of San Diego Knauss School of Business program that activates accredited angel investors and engages promising early-stage companies that drive the innovation ecosystem, announced the 13 semifinalists to move forward toward the final pitch at the SDAC V Angel Conference on April 22. Tickets available here.
A total of 106 companies applied for SDAC V, hoping to land at least $200,000 in angel investment or attract investors interested in funding additional companies*. SDAC engages new and experienced angel investors and provides coaching, an educational program, and connections to founders. Each year, the program culminates in a live and virtual final funding event. Applications for accredited angel investors are still open at www.thesdangels.com/angel-investor.
SDAC V Semifinalists include:
LIMBER Prosthetics & Orthotics
SDAC IV runner up, Somer Baburek Co-Founder & CEO of Hera Biotech, a company developing and commercializing the world’s first non-surgical test to diagnose endometriosis, says SDAC helped her company secure follow-on funding after their win at the SDAC pitch event last year.
“SDAC provided invaluable guidance and was instrumental in helping us secure $2M in our seed round. We are now in our Series A and grateful to SDAC for the coaching, connections and ongoing support. We congratulate the SDAC V semifinalists and wish them luck moving forward,” says Baburek.
With an active angel investor group of about 90 accredited investors, who invest anywhere from $7,000 to $100,000+ each conference series, the San Diego Angel Conference has become one of the largest event-based angel funds in the country.
SDAC partners with 20+ organizations in the startup ecosystem. These connections, combined with SDAC’s reputation for excellence, enables it to attract promising startups and manage a substantial investment fund. SDAC sponsors include USD, Mintz, SDSU, First Republic Bank, Coeptus Law, Aquillius, Clearpoint Agency, and UCSD.
SDAC Founder Mysty Rusk says, “Our main objectives are to activate accredited investors, and fund innovative early-stage companies. Many of these semifinalists are looking to make an impact by solving real world problems. SDAC V investors are responding to that and we are already well above our goal for the angel fund. This promises to be a record-breaking round for SDAC.”
*Actual amount invested depends on total dollars raised. Historically, investors have exceeded both the investment amount and number of companies funded.